These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6523977)

  • 1. [Effects of the new cardiotonic agent TA-064: serial computer-assisted analyses of pressure-volume relations and online myocardial 02 consumption].
    Thormann J; Kramer W; Kindler M; Neuss H; Bahawar H; Schlepper M
    Z Kardiol; 1984 Dec; 73(12):772-85. PubMed ID: 6523977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the efficacy of the new cardiotonic agent TA-064.
    Thormann J; Kramer W; Kindler M; Neuss H; Bahawar H; Schlepper M
    Am Heart J; 1985 Aug; 110(2):426-38. PubMed ID: 4025118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of the new cardiotonic agent DPI 201-106 versus dobutamine in dilated cardiomyopathy: analysis by serial pressure/volume relations and "on-line" MVO2 assessment.
    Thormann J; Kramer W; Kindler M; Kremer FP; Schlepper M
    J Cardiovasc Pharmacol; 1986; 8(4):749-57. PubMed ID: 2427814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of active components of amrinone by analysis of pressure-volume results; use of the conductance (volume) catheter technic and rapid load change by balloon occlusion of the inferior vena cava].
    Thormann J; Kramer W; Kindler M; Kremer P; Schlepper M
    Z Kardiol; 1987 Sep; 76(9):530-40. PubMed ID: 3424908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of forskolin on left ventricular function in dilated cardiomyopathy.
    Kramer W; Thormann J; Kindler M; Schlepper M
    Arzneimittelforschung; 1987 Mar; 37(3):364-7. PubMed ID: 3593453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Herz; 1991 Sep; 16 Spec No 1():298-303. PubMed ID: 1820296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of denopamine (TA-064), a new positive inotropic agent, on myocardial oxygen consumption and left ventricular dimension in anesthetized dogs.
    Ikeo T; Nagao T
    Jpn J Pharmacol; 1985 Oct; 39(2):179-89. PubMed ID: 4087565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure).
    Nikolaidis LA; Trumble D; Hentosz T; Doverspike A; Huerbin R; Mathier MA; Shen YT; Shannon RP
    Eur J Heart Fail; 2004 Jun; 6(4):409-19. PubMed ID: 15182765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
    Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
    Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and clinical effects of a new inotropic agent TA-064 in patients with refractory heart failure due to cardiomyopathy with special reference to dose-response effects.
    Matsumoto N; Matsumura K; Takahashi S; Kimata S; Hirosawa K
    Heart Vessels Suppl; 1985; 1():187-94. PubMed ID: 3843582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of a newly synthesized cardiotonic agent (TA-064) on normal and diseased hearts.
    Kino M; Hirota Y; Yamamoto S; Sawada K; Moriguchi M; Kotaka M; Kubo S; Kawamura K
    Am J Cardiol; 1983 Mar; 51(5):802-10. PubMed ID: 6829441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic therapy of congestive cardiomyopathy: effects of prenalterol and digoxin].
    Schwarz KR; Hofmann M; Mäurer W; Kadel C; von Olshausen K; Rauch B; Kübler W
    Z Kardiol; 1985 Jul; 74(7):374-83. PubMed ID: 3929486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
    Abe Y; Kitada Y; Narimatsu A
    J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.
    Ikeo T; Nagao T; Murata S; Yabana H; Sato M; Nakajima H
    Arzneimittelforschung; 1986 Jul; 36(7):1063-8. PubMed ID: 3768073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B; Sebening H; Busch U; Lutilsky L
    Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Basic Res Cardiol; 1991; 86 Suppl 1():107-12. PubMed ID: 1827977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute and sustained hemodynamic effects of a new inotropic agent TA-064 (Denopamine) in patients with refractory heart failure with special reference to dose-response effects].
    Matsumoto N; Ito N; Kawagoe Y; Matsumura K; Honda T; Horie T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1986 Oct; 34(10):1113-20. PubMed ID: 3797842
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of toborinone on myocardial oxygen consumption in pacing-induced heart failure dogs.
    Itoh S; Mori T; Fujiki H; Tominaga M
    Arzneimittelforschung; 1996 Dec; 46(12):1105-9. PubMed ID: 9006782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.